A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Adults With Metastatic Breast Cancer.

Trial Profile

A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Adults With Metastatic Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Aug 2014

At a glance

  • Drugs Falimarev (Primary) ; Inalimarev (Primary) ; Docetaxel; Sargramostim
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top